Analyst Davides holds a conference call with CEO Chowdhury to discuss the Company’s non-invasive glucose monitoring device, commercial strategy and regulatory progress with the FDA on March 29 at 10 am hosted by EF Hutton. Webcast Link
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on NMRD:
- Nemaura Medical participates in a conference call with EF Hutton
- Nemaura includes insulin on list of drugs eligible for EU DuoPack license
- Nemaura Includes Insulin on List of Drugs Eligible for EU DuoPack License Agreement
- Nemaura Medical Announces Receipt of Notice from Nasdaq
- Nemaura Medical receives Nasdaq noncompliance notice